HEMAQUEST PHARMACEUTICALS INC.

CEO: John Longenecker.

Financial information: Not disclosed.

No. of local employees: Three.

Investors: Aberdare Ventures, Forward Ventures, De Novo Ventures, Lilly Ventures Management Co. LLC and Latterell Venture Partners.

Headquarters: Tentatively moving to the San Diego region.

Year founded: 2007.

Company description: Developing drugs to treat hemoglobin diseases such as sickle cell disease.

After being headquartered in two other cities in the space of three years, HemaQuest Pharmaceuticals Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99